Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-023954

CHIEF OPERATING OFFICER sold 17,500 shares at $24.99 ($437,325)

  • CHIEF OPERATING OFFICER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Tessari Eben · CHIEF OPERATING OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-23 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $1.59 $15,900 134,475 D
2024-09-23 Sale : show line 2 in the form 10b5-1 −17,500 $24.99 $437,325 116,975 D
Open-market sales · 17,500 sh · avg $24.99 · $437,325

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-23 Exercise or conversion : show line 3 in the form 10b5-1 Share Option −10,000 36,017 D
Loading xslF345X05/form4-09252024_080916.xml…